These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 15767505

  • 1. Efficacy of aspirin plus extended-release dipyridamole in preventing recurrent stroke in high-risk populations.
    Sacco RL, Sivenius J, Diener HC.
    Arch Neurol; 2005 Mar; 62(3):403-8. PubMed ID: 15767505
    [Abstract] [Full Text] [Related]

  • 2. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS.
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [Abstract] [Full Text] [Related]

  • 3. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?
    Rouhl RP, Lodder J.
    Expert Rev Neurother; 2008 Nov; 8(11):1661-5. PubMed ID: 18986236
    [Abstract] [Full Text] [Related]

  • 4. Comparison between aspirin combined with dipyridamole versus aspirin alone within 48 hours after ischemic stroke event for prevention of recurrent stroke and improvement of neurological function: a preliminary study.
    Chairangsarit P, Sithinamsuwan P, Niyasom S, Udommongkol C, Nidhinandana S, Suwantamee J.
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S148-54. PubMed ID: 16858953
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP, Saseen JJ.
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [Abstract] [Full Text] [Related]

  • 7. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J.
    J Neurol Sci; 2009 Sep 15; 284(1-2):1-9. PubMed ID: 19380153
    [Abstract] [Full Text] [Related]

  • 8. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ.
    Curr Med Res Opin; 2007 Jun 15; 23(6):1453-62. PubMed ID: 17559741
    [Abstract] [Full Text] [Related]

  • 9. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.
    Weyrich AS, Skalabrin EJ, Kraiss LW.
    Am J Ther; 2009 Jun 15; 16(2):164-70. PubMed ID: 19300042
    [Abstract] [Full Text] [Related]

  • 10. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC.
    Int J Stroke; 2006 Feb 15; 1(1):4-8. PubMed ID: 18706062
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Secondary prevention of stroke: does dipyridamole add to aspirin?
    Lowenthal A, Buyse M.
    Acta Neurol Belg; 1994 Feb 15; 94(1):24-34. PubMed ID: 8140884
    [Abstract] [Full Text] [Related]

  • 13. Antiplatelet agents and randomized trials.
    Diener HC.
    Rev Neurol Dis; 2007 Feb 15; 4(4):177-83. PubMed ID: 18195669
    [Abstract] [Full Text] [Related]

  • 14. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb 15; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 15. The approach to optimizing stroke care.
    Panagos PD.
    Am J Emerg Med; 2008 Sep 15; 26(7):808-16. PubMed ID: 18774049
    [Abstract] [Full Text] [Related]

  • 16. Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?
    Usman MH, Notaro LA, Nagarakanti R, Brahin E, Dessain S, Gracely E, Ezekowitz MD.
    Am J Cardiol; 2009 Apr 15; 103(8):1107-12. PubMed ID: 19361598
    [Abstract] [Full Text] [Related]

  • 17. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
    Cardiovasc J Afr; 2008 Apr 15; 19(3):165. PubMed ID: 18568182
    [No Abstract] [Full Text] [Related]

  • 18. MATCH results: implications for the internist.
    Lutsep HL.
    Am J Med; 2006 Jun 15; 119(6):526.e1-7. PubMed ID: 16750967
    [Abstract] [Full Text] [Related]

  • 19. Cardiac safety in the European Stroke Prevention Study 2 (ESPS2).
    Diener HC, Darius H, Bertrand-Hardy JM, Humphreys M, European Stroke Prevention Study 2.
    Int J Clin Pract; 2001 Apr 15; 55(3):162-3. PubMed ID: 11351768
    [Abstract] [Full Text] [Related]

  • 20. Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers.
    Cadroy Y, Thalamas C, Sakariassen K, Boneu B.
    Thromb Res; 2005 Apr 15; 116(4):293-300. PubMed ID: 16038713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.